ArticleInvestigational new drugs2024

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.

Oluwadunni E Emiloju et al.PubMed ↗Publisher ↗

No numbers read from the abstract.